LUTZ, Fla., Jan. 4, 2018 /PRNewswire/ -- The new SPECTRA™: Indices of Psychopathology offers clinicians a new way to assess psychopathology in that it measures valuable clinical information on a wide range of psychopathological conditions at three levels of specificity.
The SPECTRA measures 12 clinically important constructs (depression, anxiety, social anxiety, posttraumatic stress, alcohol problems, severe aggression, antisocial behavior, drug problems, psychosis, paranoid ideation, manic activation, and grandiose ideation). These constructs are organized into three higher-order spectra of Internalizing, Externalizing, and Reality-Impairing. The constructs map on to DSM-5 conditions and help link assessment findings to the quantitative model research literature. The three spectra combine to provide a General Psychopathology Index score, which measures the total burden of psychopathology. Three supplemental scales include Cognitive Concerns, Psychosocial Functioning, and Suicidal Ideations.
"Whether addressing discrete disorders or continuous dimensions, psychopathology can demonstrate substantial comorbidity," stated Kristin Greco, MBA, PAR CEO. "Research shows these three higher-order spectra of Internalizing, Externalizing, and Reality-Impairing dimensions can offer clinicians a well-researched model for conceptualizing, measuring, and treating psychiatric concerns."
The SPECTRA takes just 15-20 minutes to administer and can be administered and scored on paper or via the PARiConnect online assessment system. The SPECTRA is useful when evaluating individuals in a variety of clinical settings, such as inpatient and outpatient clinics, hospitals, schools, and forensic settings. It also can help track progress over time if administered repeatedly.
To learn more about the SPECTRA, visit www.parinc.com, or call PAR Customer Support at 1.800.331.8378.
Founded in 1978, PAR is a leading publisher of assessment instruments, software, and other related materials. Over the past three decades, PAR has earned a reputation for providing customers with innovative assessment solutions and unparalleled customer service.
Advertisement
The SPECTRA measures 12 clinically important constructs (depression, anxiety, social anxiety, posttraumatic stress, alcohol problems, severe aggression, antisocial behavior, drug problems, psychosis, paranoid ideation, manic activation, and grandiose ideation). These constructs are organized into three higher-order spectra of Internalizing, Externalizing, and Reality-Impairing. The constructs map on to DSM-5 conditions and help link assessment findings to the quantitative model research literature. The three spectra combine to provide a General Psychopathology Index score, which measures the total burden of psychopathology. Three supplemental scales include Cognitive Concerns, Psychosocial Functioning, and Suicidal Ideations.
Advertisement
"Whether addressing discrete disorders or continuous dimensions, psychopathology can demonstrate substantial comorbidity," stated Kristin Greco, MBA, PAR CEO. "Research shows these three higher-order spectra of Internalizing, Externalizing, and Reality-Impairing dimensions can offer clinicians a well-researched model for conceptualizing, measuring, and treating psychiatric concerns."
The SPECTRA takes just 15-20 minutes to administer and can be administered and scored on paper or via the PARiConnect online assessment system. The SPECTRA is useful when evaluating individuals in a variety of clinical settings, such as inpatient and outpatient clinics, hospitals, schools, and forensic settings. It also can help track progress over time if administered repeatedly.
To learn more about the SPECTRA, visit www.parinc.com, or call PAR Customer Support at 1.800.331.8378.
Founded in 1978, PAR is a leading publisher of assessment instruments, software, and other related materials. Over the past three decades, PAR has earned a reputation for providing customers with innovative assessment solutions and unparalleled customer service.
View original content:http://www.prnewswire.com/news-releases/a-new-measure-of-psychopathology-offers-clinicians-advantages-over-similar-tests-300577789.html
SOURCE PAR
